Saturday 17 October 2026 Export CHE’s income statement to Excel — free account

Chemed Corporation

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024. In the quarter to June 2026, revenue grew 8.80%, EPS grew 42.8% and free cash flow fell 43.5%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years, revenue growth for three.

512.38 3.06 −0.59%

Follow CHE

Alert me

Market cap: $6.7B
P/E: 25.7×
Fwd P/E: 20.4×
Dividend yield: 0.49%
F-score: 6/9
Altman Z: 11.69
Beneish M: −2.76
Dividend safety: 100/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 8.76

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	1	—	—	—	2	—	3	1	1	3	2	—

Insider Ownership 2.69%

Capital & Financial Ratios $m

Market Cap 6,740.00

Revenue 2,595.00

Net Income 274.99

Free Cash Flow 328.12

Net Debt 99.78

Current Ratio 0.91

Debt/Equity 0.17

P/E ratio 25.71

Fwd P/E 20.40

P/S ratio 2.60

P/B ratio 8.13

Past 5Y EPS Growth (1.20%)

This Y EPS Growth 18.30%

Next Y EPS Growth 7.94%

Next Y revenue growth 7.55%

Next 5Y EPS Growth 11.95%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 34.54%

10-year low 10-year high

P/S against its own 10 years 29.60%

10-year low 10-year high

P/B against its own 10 years 47.62%

10-year low 10-year high

EV/Sales against its own 10 years 30.85%

10-year low 10-year high

EV/FCF against its own 10 years 30.70%

10-year low 10-year high

Dividends

Payout Ratio 0.13

Annual Dividend Rate 2.50

Annual Dividend Yield 0.49%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	2.43	0.60 0.60 0.70
2025	2.20	0.50 0.50 0.60 0.60
2024	1.80	0.40 0.40 0.50 0.50
2023	1.56	0.38 0.38 0.40 0.40
2022	1.48	0.36 0.36 0.38 0.38
2021	1.40	0.34 0.34 0.36 0.36
2020	1.32	0.32 0.32 0.34 0.34
2019	1.24	0.30 0.30 0.32 0.32
2018	1.16	0.28 0.28 0.30 0.30
2017	1.08	0.26 0.26 0.28 0.28
2016	1.00	0.24 0.24 0.26 0.26

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	264	178	75	40
Receivables	182	171	183	189
Inventory	12	8	8	8
Other	—	—	—	—
	501	395	303	291

	2023	2024	2025	Q'26
Payables	64	44	64	85
ST’ Debt	—	—	—	—
Other	56	43	59	58
	312	286	287	320

Compound Annual Growth %

	10y	5y	3y
Sales	5.07%	4.00%	5.82%
Cash Flow	8.51%	(4.52%)	7.81%
Earnings	9.17%	(3.65%)	2.04%
Book Value	6.68%	1.68%	7.03%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	658	673	—	—	—
’25	647	619	625	639	2,530
’24	589	596	606	640	2,431
’23	560	554	565	586	2,264
’22	531	531	526	547	2,135
’21	527	532	539	541	2,139
’20	516	502	528	533	2,080

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	88	85	—	—	—
’25	33	139	83	134	388
’24	85	78	91	165	417
’23	60	132	29	109	330
’22	101	57	52	100	310
’21	107	25	113	64	309
’20	89	188	125	87	489

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	71	70	—	—	—
’25	20	123	69	118	330
’24	72	69	77	152	371
’23	44	116	17	97	274
’22	89	45	39	82	255
’21	89	10	102	50	251
’20	69	176	114	72	432

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	4.84	5.13	—	—	—
’25	4.86	3.57	4.46	5.48	18.34
’24	4.24	4.65	5.00	6.02	19.89
’23	3.58	3.51	4.93	5.90	17.93
’22	4.22	4.40	3.78	4.13	16.53
’21	4.01	3.51	4.55	4.81	16.85
’20	3.38	5.01	4.14	6.96	19.48

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	124.77	158.60	243.68	265.08	330.01	403.00	430.16	481.99	512.12	408.42	Analyst estimates 2026–2028 Powerpack
	High	164.07	251.00	335.99	445.10	543.81	560.00	530.72	596.91	654.62	623.61
People
People	Employees	14,613	14,813	15,707	16,641	15,544	14,137	14,167	15,087	15,695	15,811
	Revenue/emp, $m	0.11	0.11	0.11	0.12	0.13	0.15	0.15	0.15	0.15	0.16
Income, $m
Income, $m	Revenue	1,577	1,667	1,783	1,939	2,080	2,139	2,135	2,264	2,431	2,530
	Gross margin, %	29.26	30.97	31.13	31.85	33.73	35.98	35.84	35.28	35.14	32.54
	EBT	177	117	240	262	396	350	330	350	399	356
	EBT margin, %	11.23	7.01	13.44	13.50	19.04	16.38	15.44	15.47	16.43	14.06
	Net income	109	98	206	220	319	269	250	273	302	265
	Depreciation	37	37	40	46	57	59	60	61	63	65
Per share, $
Per share, $	Revenue	96.25	103.80	111.01	121.39	130.34	136.51	143.01	150.46	161.83	175.72
	Earnings	6.64	6.11	12.80	13.77	20.02	17.14	16.72	18.11	20.10	18.42
	Cash flow	8.26	10.12	17.88	18.86	30.67	19.69	20.76	21.95	27.79	26.97
	Capex	(2.43)	(4.00)	(3.29)	(3.32)	(3.58)	(3.69)	(3.68)	(3.74)	(3.08)	(4.04)
	Free cash flow	5.84	6.12	14.59	15.54	27.09	16.01	17.07	18.21	24.71	22.92
	Book value	31.99	33.65	36.82	45.50	56.48	39.77	53.50	73.61	74.48	68.02
	Shares, m	16	16	16	16	16	16	15	15	15	14
Valuation, ×
Valuation, ×	P/E	24.38	40.42	22.13	31.92	26.59	30.83	30.32	32.31	26.33	23.19
	P/S	1.68	2.38	2.55	3.62	4.09	3.88	3.54	3.89	3.27	2.43
	P/B	5.07	7.34	7.69	9.65	9.43	13.30	9.47	7.94	7.11	6.29
	EV/Sales	1.74	2.43	2.60	3.69	4.07	3.97	3.56	3.81	3.24	2.45
	EV/FCF	28.75	41.30	19.82	28.79	19.60	33.86	29.78	31.52	21.24	18.75
Cash, $m
Cash, $m	Operating cash flow	135	162	287	301	489	309	310	330	417	388
	Capex	(40)	(64)	(53)	(53)	(57)	(58)	(55)	(56)	(46)	(58)
	Free cash flow	96	98	234	248	432	251	255	274	371	330
Balance, $m
Balance, $m	Working capital	(2)	(17)	(32)	(72)	30	(72)	(25)	189	109	15
	Total debt	109	101	103	139	135	235	98	—	—	—
	Net debt	93	90	98	133	(28)	202	23	(264)	(178)	(75)
	Shareholders’ equity	524	540	591	727	901	623	799	1,108	1,119	979
Returns, %
Returns, %	ROA	12.55	10.91	21.69	19.60	23.64	19.34	17.93	17.52	18.10	16.54
	ROIC	18.09	11.21	22.08	18.72	27.88	25.98	26.11	25.22	24.35	23.36
	ROE	20.97	18.45	36.33	33.37	39.25	35.23	35.11	28.59	27.12	25.28

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
FMS Fresenius Medical Care AG & Co. KGaA	$11.8B	11.5×	12.5×	+3.89% (above 0%: growing)	+6.82% (above 0%: growing)	+1.57% (above 0%: growing)	26.95%	9.58%	Compare
UHS Universal Health Services, Inc.	$11.0B	7.5×	6.1×	+8.27% (above 0%: growing)	+9.47% (above 0%: growing)	−23.78% (below 0%: shrinking)	90.87%	11.14%	Compare
ENSG The Ensign Group, Inc.	$10.4B	26.9×	24.1×	+17.33% (above 0%: growing)	+16.22% (above 0%: growing)	+12.24% (above 0%: growing)	16.65%	8.50%	Compare
PACS PACS Group, Inc.	$7.6B	27.6×	16.8×	+9.07% (above 0%: growing)	+45.45% (above 0%: growing)	+220.51% (above 0%: growing)	17.07%	7.66%	Compare
CHE Chemed Corporation	$6.7B	25.7×	20.4×	+8.80% (above 0%: growing)	+42.78% (above 0%: growing)	−43.51% (below 0%: shrinking)	32.90%	13.25%
CON Concentra Group Holdings Parent, Inc.	$5.0B	24.9×	17.0×	+10.03% (above 0%: growing)	+45.71% (above 0%: growing)	+91.62% (above 0%: growing)	31.70%	18.99%	Compare
LFST LifeStance Health Group, Inc.	$4.7B	88.3×	58.5×	+26.08% (above 0%: growing)	n/m	+55.22% (above 0%: growing)	35.15%	7.04%	Compare
OPCH Option Care Health, Inc.	$4.7B	23.5×	14.1×	+1.86% (above 0%: growing)	+12.90% (above 0%: growing)	+112.36% (above 0%: growing)	18.53%	5.90%	Compare
NHC National HealthCare Corporation	$3.9B	26.9×	8.4×	+8.83% (above 0%: growing)	+68.63% (above 0%: growing)	−41.57% (below 0%: shrinking)	100.00%	11.99%	Compare
Median of peers	$6.3B	25.9×	15.5×	+8.95%	+16.22%	+33.73%	29.33%	9.04%

All 55 Medical Care Facilities stocks →

Chemed Corporation (CHE) key facts

Concern: Net income was $265.2 million, or $18.42 per share (basic), a net margin of 10.5%.
Strength: Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
Chemed Corporation (CHE) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, CHE traded at $512.38, a market capitalization of $6.7 billion.
At that price the stock trades at 25.7× trailing-twelve-month earnings and 2.6× sales; its P/E is higher than 35% of its own readings over the past ten years.
Chemed Corporation pays an annual dividend of $2.50 per share, a yield of 0.49%, with a payout ratio of 12.6%.
Return on equity was 25.3% and debt-to-equity 0.17.
Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 11.69 (safe zone) for fiscal 2025.